Journal of Infectious Diseases and Medical Microbiology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-7360-538437

Case Report - Journal of Infectious Diseases and Medical Microbiology (2022) Volume 6, Issue 6

Novel antiviral and anitbacterial drugs and novel drug supplement interactions

Novel Covid previously showed up in Wuhan, China, in December 2019, and it rapidly extended all around the world. A few meds which are utilized to treat different illnesses appear to be compelling in treating Coronavirus even without express help. The current medications that are summed up in this audit fundamentally centered on remedial specialists that had action against other RNA infections like MERS-CoV and SARS-CoV. Drug reusing or repositioning is a promising field in drug disclosure that distinguishes new helpful open doors for existing medications like corticosteroids, RNA-subordinate RNA polymerase inhibitors, interferons, protease inhibitors, ivermectin, melatonin, teicoplanin, and some others.

Author(s): John Shelby

Abstract Full Text PDF

Get the App

Vizag Tech Summit